Cargando…
Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a hematologic malignancy associated with high morbidity and mortality. Here we describe a case of a patient with AML who presented a partial response after utilization of the non-steroidal anti-inflammatory drug nimesulide. The response was characterized by complete c...
Autores principales: | Tomaz, Victória, Griesi-Oliveira, Karina, Puga, Renato D., Conti, Bruno J., Santos, Fabio P. S., Hamerschlak, Nelson, Campregher, Paulo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215211/ https://www.ncbi.nlm.nih.gov/pubmed/35756679 http://dx.doi.org/10.3389/fonc.2022.874168 |
Ejemplares similares
-
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016) -
Successful treatment of post-transplant relapsed acute myeloid leukemia with FLT3 internal tandem duplication using the combination of induction chemotherapy, donor lymphocyte infusion, sorafenib and azacitidine. Report of three cases
por: Campregher, Paulo Vidal, et al.
Publicado: (2017) -
Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015) -
Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Campregher, Paulo Vidal, et al.
Publicado: (2012) -
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)